Abstract: Senescence-associated extracellular vesicles in skin aging and regeneration
This abstract describes how senescent skin cells release senescence-associated extracellular vesicles (SA-EVs) that spread senescence to nearby cells, impair wound healing and contribute to chronic wounds, diabetic ulcers, burns, pathological scarring and skin ageing; senolytic, senomorphic and regenerative EV approaches are named as possible therapeutic options. [1]
Automatic summary · not editorially reviewed
The key findings
Senescent cells release SA-EVs with higher secretion rates, altered formation and selective cargo including proinflammatory microRNAs, cytokines, mitochondrial DNA, EphA2 protein and noncoding RNAs. [1]
SA-EVs promote senescence in a paracrine manner and impair wound healing, and are linked to chronic wounds, diabetic ulcers, burns, pathological scarring and skin ageing. [1]
Approaches reducing the SA-EV burden can be senolytic or senomorphic, while mesenchymal stem cell-derived EVs, modified EV platforms and biomaterial-assisted systems are called promising therapeutic options. [1]
The source at a glance
- Study type / format
- Abstract of a review-style article
- Population / context
- Skin cells and skin, as described in the abstract
- Summary based on
- Study abstract
- Original publication
- September 22, 2026
Senescent skin cells and their vesicle cargo
The abstract states that cellular senescence impairs skin homeostasis and regeneration through chronic inflammation, breakdown of the extracellular matrix, loss of stem cells and impaired blood vessel formation. Besides the known senescence-associated secretory phenotype (SASP), senescent cells release SA-EVs as signalling molecules. These vesicles are marked by higher secretion rates, altered formation and selective cargo loading, including proinflammatory microRNAs, cytokines, mitochondrial DNA, the EphA2 protein and noncoding RNAs (tRNAs, lncRNAs, snoRNAs).
Supporting source [1]
Paracrine spread and skin conditions named
According to the abstract, SA-EVs promote senescence in a paracrine manner, meaning they can induce senescence in neighbouring cells. They are said to impair the wound healing process and to contribute to chronic wounds, diabetic ulcers, burns, pathological scarring, skin ageing and other skin disorders. These are described associations in the abstract, not proof that SA-EVs cause these conditions.
Supporting source [1]
Proposed senolytic, senomorphic and EV strategies
The abstract names treatment approaches that aim to reduce the SA-EV burden: senolytic or senomorphic strategies. It also calls regenerative extracellular vesicles derived from mesenchymal stem cells, modified EV platforms and biomaterial-assisted systems promising therapeutic options. These are proposed directions described in an abstract, not validated treatments or demonstrated benefits for patients.
Supporting source [1]
How to interpret this
This is an abstract; the full text was not reviewed. It reports no study design, sample, follow-up or measured outcomes, and the therapeutic options are described as promising rather than demonstrated.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Muttiah B, Venkatraman G. · europepmc.org · September 22, 2026